Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rectal Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01126866
What this trial is testing

Curative Resectability of Not Optimally Resectable Liver and/or Lung Metastases From Colorectal Carcinoma (CRC) Under Intensified Chemotherapy

Who this might be right for
Colorectal Carcinoma
National Center for Tumor Diseases, Heidelberg 35
Testing effectiveness (Phase 2)Study completedNCT00630786
What this trial is testing

Conatumumab/Panitumumab Combination Metastatic Colorectal Cancer Study

Who this might be right for
Colon CancerColorectal CancerRectal Cancer+2 more
Amgen 53
Testing effectiveness (Phase 2)Study completedNCT03206073
What this trial is testing

A Phase I/II Study of Pexa-Vec Oncolytic Virus in Combination With Immune Checkpoint Inhibition in Refractory Colorectal Cancer

Who this might be right for
Colorectal CancerColorectal CarcinomaColorectal Adenocarcinoma+2 more
National Cancer Institute (NCI) 34
Early research (Phase 1)WithdrawnNCT06626256
What this trial is testing

STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma

Who this might be right for
Locally Advanced Cervical CarcinomaLocally Advanced Colorectal CarcinomaLocally Advanced Malignant Solid Neoplasm+24 more
City of Hope Medical Center
Testing effectiveness (Phase 2)UnknownNCT01348256
What this trial is testing

Study With Dendritic Cell Immunotherapy in Resected Hepatic Metastasis of Colorectal Carcinoma

Who this might be right for
Colorectal CarcinomaHepatic Metastasis
Clinica Universidad de Navarra, Universidad de Navarra 58
Testing effectiveness (Phase 2)Looking for participantsNCT05806931
What this trial is testing

Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer

Who this might be right for
Colon CancerRectal Cancer
Rutgers, The State University of New Jersey 50
Not applicableActive Not RecruitingNCT06814093
What this trial is testing

Robotic Versus Laparoscopic Surgery for Middle and Low Rectal Cancer: a Target Trial Emulation

Who this might be right for
Rectal Cancer
Xu jianmin 2,702
Not applicableStudy completedNCT04880772
What this trial is testing

Clinical Trial Comparing Standard Care Versus Prehabilitation in Patients Undergoing Cancer Surgery

Who this might be right for
Cancer of ColonCancer of RectumLiver Metastases
East Lancashire Hospitals NHS Trust 42
Testing effectiveness (Phase 2)WithdrawnNCT04418895
What this trial is testing

Neoadjuvant Therapy for Localized Rectal Adenocarcinoma

Who this might be right for
Rectal Adenocarcinoma
UNC Lineberger Comprehensive Cancer Center
Not applicableStudy completedNCT00969657
What this trial is testing

Validation of a Predictive Model After Complete Response in Rectal Cancer

Who this might be right for
Rectal Cancer
Maastricht Radiation Oncology 80
Early research (Phase 1)Study completedNCT00611000
What this trial is testing

Effect of Folate on DNA in Colon Tissue and Blood Samples From Patients at Increased Risk of Developing Colorectal Neoplasia

Who this might be right for
Colorectal Cancer
Rockefeller University 20
Not applicableLooking for participantsNCT06574087
What this trial is testing

Determining the Frequency of Occurrence and Defining the Most Appropriate Screening Test for Anal Intraepithelial Neoplasia (AIN) in Patients With Human Papillomavirus (HPV) Related Gynecological Diseases.

Who this might be right for
HPV-Related CarcinomaHPV Infection
PCK Marine Hospital in Gdynia 248
Not applicableNot Yet RecruitingNCT07689812
What this trial is testing

Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Carcinoma)+12 more
Natera, Inc. 920
Testing effectiveness (Phase 2)Looking for participantsNCT07198165
What this trial is testing

SCRT Followed by CAPOX + Bev ± PD-1 Inhibitor for TNT in LARC

Who this might be right for
Rectal CancerRectal AdenocarcinomaRectal Cancer, Radiotherapy+6 more
Ruijin Hospital 104
Not applicableStudy completedNCT01656044
What this trial is testing

Negative Pressure Therapy in Preventing Infection After Surgery in Patients With Colon, Rectal, Pancreatic, or Peritoneal Surface Cancer

Who this might be right for
Colon CancerPancreatic CancerPerioperative/Postoperative Complications+2 more
Wake Forest University Health Sciences 375
Not applicableStudy completedNCT04444232
What this trial is testing

Cancer Communication Within Hispanic Social Networks

Who this might be right for
Colorectal Carcinoma
Fred Hutchinson Cancer Center 57
Not applicableStudy completedNCT00900302
What this trial is testing

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Who this might be right for
Cancer
OHSU Knight Cancer Institute 98
Not applicableWithdrawnNCT00651677
What this trial is testing

Hand Assisted Versus "Pure" Laparoscopic Assisted Proctectomy for Rectal Cancer

Who this might be right for
Rectal Cancer
Weill Medical College of Cornell University
Not applicableStudy completedNCT01511653
What this trial is testing

Validation of Colon Biomarkers for the Early Detection of Colorectal Adenocarcinoma

Who this might be right for
Colon CancerRectal Cancer
University of Michigan 13,000
Testing effectiveness (Phase 2)Looking for participantsNCT06128551
What this trial is testing

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)Colorectal CancerPancreatic Ductal Adenocarcinoma
Revolution Medicines, Inc. 534
Next Page